Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
出版年份 2021 全文链接
标题
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
作者
关键词
-
出版物
Cell Host & Microbe
Volume 30, Issue 1, Pages 97-109.e5
出版商
Elsevier BV
发表日期
2021-12-03
DOI
10.1016/j.chom.2021.12.004
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK
- (2021) Julian W. Tang et al. JOURNAL OF INFECTION
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- The great escape? SARS-CoV-2 variants evading neutralizing responses
- (2021) Jérémie Prévost et al. Cell Host & Microbe
- Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV
- (2021) Jnanendra Prasad Sarkar et al. INFECTION GENETICS AND EVOLUTION
- Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
- (2021) Ester C Sabino et al. LANCET
- Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
- (2021) Dami A. Collier et al. NATURE
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
- (2021) Nicholas G. Davies et al. SCIENCE
- High‐throughput detection of antibodies targeting the SARS‐CoV ‐2 Spike in longitudinal convalescent plasma samples
- (2021) Sai Priya Anand et al. TRANSFUSION
- Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
- (2021) Jennifer Hicks et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
- (2021) Leonidas Stamatatos et al. SCIENCE
- Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021
- (2021) Tamara Pilishvili et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination
- (2021) Rishi R. Goel et al. Science Immunology
- A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
- (2021) Alexandra Tauzin et al. Cell Host & Microbe
- Cross-reactive antibody immunity against SARS-CoV-2 in children and adults
- (2021) Elizabeth Fraley et al. Cellular & Molecular Immunology
- Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
- (2021) Irfan Ullah et al. IMMUNITY
- Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination
- (2021) Mark M. Painter et al. IMMUNITY
- Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
- (2021) Jérémie Prévost et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
- (2021) Emma C Wall et al. LANCET
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York
- (2021) Medini K. Annavajhala et al. NATURE
- Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
- (2021) Zijun Wang et al. NATURE
- Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection
- (2021) Richard A. Urbanowicz et al. Science Translational Medicine
- Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations
- (2021) Shai Efrati et al. Scientific Reports
- Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects
- (2021) Madeleine F. Jennewein et al. Cell Reports
- Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals
- (2021) Daniel Lozano-Ojalvo et al. Cell Reports
- Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
- (2021) Helen Parry et al. Immunity & Ageing
- Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
- (2021) Rebecca P. Payne et al. CELL
- Waning Immunity after the BNT162b2 Vaccine in Israel
- (2021) Yair Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
- (2021) Rishi R. Goel et al. SCIENCE
- Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity
- (2021) Shang Yu Gong et al. VIROLOGY
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- SARS-CoV-2 vaccines: ‘Warp Speed’ needs mind melds not warped minds
- (2020) John P. Moore et al. JOURNAL OF VIROLOGY
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
- (2020) Antonio E. Muruato et al. Nature Communications
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
- (2020) Guillaume Beaudoin-Bussières et al. mBio
- Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide
- (2020) Sandra Isabel et al. Scientific Reports
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Urea-mediated dissociation alleviate the false-positive Treponema pallidum-specific antibodies detected by ELISA
- (2019) Qiang Wang et al. PLoS One
- Comparison of different enzyme-linked immunosorbent assay methods for avidity determination of antiphospholipid antibodies
- (2017) Lenka Fialová et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism
- (2016) Jung-Eun Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential Sensitivity of Bat Cells to Infection by Enveloped RNA Viruses: Coronaviruses, Paramyxoviruses, Filoviruses, and Influenza Viruses
- (2013) Markus Hoffmann et al. PLoS One
- Affinity and Avidity in Antibody-Based Tumor Targeting
- (2009) Stephen I. Rudnick et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started